DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Ciardiello F. et al.
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX.
Ann Oncol 2016;
27: 1055-1061
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.